TY - JOUR
T1 - Dietary Approaches to Stop Hypertension Diet and Activity to Limit Gestational Weight
T2 - Maternal Offspring Metabolics Family Intervention Trial, a Technology Enhanced Randomized Trial
AU - Van Horn, Linda
AU - Peaceman, Alan
AU - Kwasny, Mary
AU - Vincent, Eileen
AU - Fought, Angela
AU - Josefson, Jami
AU - Spring, Bonnie
AU - Neff, Lisa M.
AU - Gernhofer, Niki
N1 - Funding Information:
Lifestyle Interventions for Expectant Moms (LIFE-Moms) is supported by NIH through the National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK094418, U01 DK094463, U01 DK094416, 5U01 DK094466 [RCU]); the National Heart, Lung, and Blood Institute (U01 HL114344); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01 HD072834); the National Center for Complementary and Integrative Health; the NIH Office of Research in Women's Health; the Office of Behavioral and Social Science Research; the Indian Health Service; and the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. We thank the LIFE-Moms consortium members for their contributions to the development and oversight of the common measures and procedures shared across the trials. We thank our participants for their selflessness and enthusiasm.
Publisher Copyright:
© 2018 American Journal of Preventive Medicine
PY - 2018/11
Y1 - 2018/11
N2 - Introduction: Technology-enhanced antenatal diet and lifestyle intervention could prevent excess gestational weight gain and benefit mother and child. Study design: A randomized clinical trial. Setting/participants: Overweight and obese ethnically diverse pregnant women in Chicago, Illinois, were enrolled between October 2012 and December 2015, with antenatal data collection completed by July 2016. Analysis was completed June 2017. Intervention: Participants were randomized when their fetus was gestational age 16 weeks to dietitian-led Dietary Approaches to Stop Hypertension diet and physical activity coaching that was received as three individual and six group counseling sessions by phone and webinar. A commercially available smartphone application was used for self-monitoring diet and physical activity. Telephone, text message prompts, and e-mail reminders encouraged adherence and website viewing. Usual-care, “web-watcher” participants were e-mailed biweekly newsletters and publicly available maternity website links. Main outcome measures: The primary outcome was gestational weight gain measured at baseline, 24 weeks, and 35.0–36.6 weeks. Secondary outcomes included weekly rate of gestational weight gain, newborn anthropometrics, maternal diet quality, physical activity, and blood pressure. Results: Among 281 participants randomized (n=140 in intervention, n=141 in usual care, BMI 25 to <40, and age range 18–40 years), 37% were non-white and 274 completed antenatal data collection (n=139 in the intervention group and n=135 in the usual-care group). Gestational weight gain differed significantly by intervention group (difference, 1.7 kg, p=0.01) and rate of weight gain was 0.4 (SD=0.2) vs 0.5 (SD=0.2) kg/week. No significant differences were noted in birth weight, percentage body fat, or adverse pregnancy outcomes, but more cesarean sections (55 [40%] vs 37 [27%]) occurred among the intervention group. Conclusions: Technology-enhanced Dietary Approaches to Stop Hypertension diet and lifestyle intervention resulted in significantly less total gestational weight gain over 35 weeks with no adverse infant outcomes. Nutrient quality improved without an adverse impact on rate of prematurity. Increased cesarean delivery requires further exploration. The National Academy of Medicine goals were not achieved by the majority of participants. Obesity prevention preconception is needed. Trial registration: This study is registered at www.clinicaltrials.gov NCT01631747.
AB - Introduction: Technology-enhanced antenatal diet and lifestyle intervention could prevent excess gestational weight gain and benefit mother and child. Study design: A randomized clinical trial. Setting/participants: Overweight and obese ethnically diverse pregnant women in Chicago, Illinois, were enrolled between October 2012 and December 2015, with antenatal data collection completed by July 2016. Analysis was completed June 2017. Intervention: Participants were randomized when their fetus was gestational age 16 weeks to dietitian-led Dietary Approaches to Stop Hypertension diet and physical activity coaching that was received as three individual and six group counseling sessions by phone and webinar. A commercially available smartphone application was used for self-monitoring diet and physical activity. Telephone, text message prompts, and e-mail reminders encouraged adherence and website viewing. Usual-care, “web-watcher” participants were e-mailed biweekly newsletters and publicly available maternity website links. Main outcome measures: The primary outcome was gestational weight gain measured at baseline, 24 weeks, and 35.0–36.6 weeks. Secondary outcomes included weekly rate of gestational weight gain, newborn anthropometrics, maternal diet quality, physical activity, and blood pressure. Results: Among 281 participants randomized (n=140 in intervention, n=141 in usual care, BMI 25 to <40, and age range 18–40 years), 37% were non-white and 274 completed antenatal data collection (n=139 in the intervention group and n=135 in the usual-care group). Gestational weight gain differed significantly by intervention group (difference, 1.7 kg, p=0.01) and rate of weight gain was 0.4 (SD=0.2) vs 0.5 (SD=0.2) kg/week. No significant differences were noted in birth weight, percentage body fat, or adverse pregnancy outcomes, but more cesarean sections (55 [40%] vs 37 [27%]) occurred among the intervention group. Conclusions: Technology-enhanced Dietary Approaches to Stop Hypertension diet and lifestyle intervention resulted in significantly less total gestational weight gain over 35 weeks with no adverse infant outcomes. Nutrient quality improved without an adverse impact on rate of prematurity. Increased cesarean delivery requires further exploration. The National Academy of Medicine goals were not achieved by the majority of participants. Obesity prevention preconception is needed. Trial registration: This study is registered at www.clinicaltrials.gov NCT01631747.
UR - http://www.scopus.com/inward/record.url?scp=85055076181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055076181&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2018.06.015
DO - 10.1016/j.amepre.2018.06.015
M3 - Article
C2 - 30262148
AN - SCOPUS:85055076181
SN - 0749-3797
VL - 55
SP - 603
EP - 614
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 5
ER -